谷氨酸羧肽酶Ⅱ
前列腺癌
前列腺特异性抗原
医学
抗原
前列腺
肿瘤科
内科学
癌症研究
癌症
免疫学
出处
期刊:PubMed
日期:2018-02-01
卷期号:56 (2): 91-94
标识
DOI:10.3760/cma.j.issn.0529-5815.2018.02.002
摘要
Recently, prostate cancer has become the most common male urological cancer worldwide. However, it was difficult for the currently widely available imaging modalities to precisely diagnose this disease. With the development of nuclear medical technology, molecular imaging targeting prostate specific membrane antigen has been introduced into China. To promote the standardization of this imaging modality, the experts consensus was published by Chinese Anticancer Association Genitourinary Oncology Committee and recommendations for its application in the diagnosis and treatment of prostate cancer were attached, which would be helpful for doctors who are conducting or preparing for this examination.前列腺癌近年来已成为发病率最高的男性泌尿系统恶性肿瘤,现有影像学检查手段在指导前列腺癌诊疗方面的价值有限。随着核医学技术的进步,前列腺特异性膜抗原靶向分子影像检查在我国逐渐开展。为进一步提高该检查应用的规范性,中国抗癌协会泌尿男生殖系肿瘤专业委员会特组织专家制定本共识,对前列腺特异性膜抗原靶向分子影像检查在前列腺诊疗方面的应用提出推荐意见,供正在开展或准备开展该技术的医师参考。.
科研通智能强力驱动
Strongly Powered by AbleSci AI